S. Boukas

发表

Preventable death classification: interrater reliability and comparison with ISS-based survival probability estimates.

J. Sampalis, A. Lavoie, S. Boukas, 1995, Accident; analysis and prevention.

Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial

J. Sampalis, E. Rampakakis, S. Boukas, 2011, Archives of medical science : AMS.

A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study

J. Sampalis, M. Madan, E. Rampakakis, 2012, Advances in preventive medicine.

Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.

J. Sampalis, E. Rampakakis, S. Boukas, 2017, Surgery.

Co-administration of ezetimibe and a statin in management of dyslipidemias: a meta-analysis of clinical trials

J. Sampalis, S. Boukas, Robert Nathanson, 2009 .

Clinical research Co-administration of ezetimibe and a statin in management of dyslipidemias: a meta-analysis of clinical trials

J. Sampalis, S. Boukas, Robert Nathanson, 2009 .

Trauma care regionalization: a process-outcome evaluation.

J. Sampalis, D. Mulder, R. Denis, 1999, The Journal of trauma.

Ineffectiveness of on-site intravenous lines: is prehospital time the culprit?

J. Williams, J. Sampalis, D. Mulder, 1997, The Journal of trauma.

Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting.

J. Sampalis, G. Dupuis, M. Liberman, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Preventable death evaluation of the appropriateness of the on-site trauma care provided by Urgences-Santé physicians.

J. Sampalis, D. Mulder, P. Fréchette, 1995, The Journal of trauma.

Trauma Center Designation

J. Sampalis, D. Mulder, R. Denis, 1995 .

Trauma Center Designation

J. Sampalis, R. Denis, P. Fréchette, 1994 .

Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

J. Sampalis, S. Boukas, Stéphane Bissonnette, 2006, The Canadian journal of cardiology.

Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin

J. Sampalis, S. Boukas, Stéphane Bissonnette, 2007, The Annals of pharmacotherapy.

Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE Model

J. Sampalis, S. Boukas, Stéphane Bissonnette, 2010, Advances in preventive medicine.

Trauma center designation: initial impact on trauma-related mortality.

P. Fréchette, S. Boukas, J. S. Sampalis, 1995, The Journal of trauma.